Drug Shortage Report for TEVA-LOSARTAN
Report ID | 88192 |
Drug Identification Number | 02357976 |
Brand name | TEVA-LOSARTAN |
Common or Proper name | LOSARTAN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LOSARTAN POTASSIUM |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-07-02 |
Estimated end date | 2019-11-30 |
Actual end date | 2019-10-31 |
Shortage status | Resolved |
Updated date | 2019-11-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-02 | English | Compare |
v2 | 2019-07-02 | French | Compare |
v3 | 2019-07-03 | English | Compare |
v4 | 2019-08-06 | English | Compare |
v5 | 2019-08-06 | French | Compare |
v6 | 2019-08-22 | English | Compare |
v7 | 2019-08-22 | French | Compare |
v8 | 2019-09-26 | English | Compare |
v9 | 2019-09-26 | French | Compare |
v10 | 2019-10-31 | English | Compare |
v11 | 2019-10-31 | French | Compare |
v12 | 2019-11-01 | English | Compare |
Showing 1 to 12 of 12